Method for controlling defrost in refrigeration systems
11079163 · 2021-08-03
Assignee
Inventors
- Teddy Glenn Bostic, Jr. (Summerville, SC, US)
- Gregory Joseph Deutschmann (Mt. Pleasant, SC, US)
- Chang H. Luh (Summerville, SC, US)
- Laura Steiner (Mt. Pleasant, SC, US)
Cpc classification
F25D21/008
MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
F25D2700/10
MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
F25D21/12
MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
F25D2500/02
MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
F25D17/06
MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
F25D11/006
MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
F25D21/006
MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
International classification
F25D21/12
MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
Abstract
Automatic defrost technology for refrigeration equipment, in particular, defrosting refrigeration equipment by acceleration defrosting sublimation effects in refrigeration chambers in continual operation below the freezing point of water. Useful for refrigeration equipment for storage of vaccines and other products having storage temperatures ranging from −58 degrees Fahrenheit and 5 degrees Fahrenheit.
Claims
1. A refrigeration defrost system for a refrigerator wherein said refrigeration defrost system is used for storage of vaccines or other products having such low temperature storage requirements, said refrigeration defrost system comprises: a digital controller for measuring temperatures and regulating the operation of the refrigeration system including initiating a refrigeration defrost cycle; a condenser having metal tubing ranging in length from 180 to 240 inches; a hermetically sealed compressor; an evaporator having metal tubing ranging in length of 80 to 160 inches; wherein said evaporator further having fins for heat transfer and an integrated heating element and an expansion device, wherein said evaporator is positioned in an evaporator chamber; when said heating element of said evaporator becomes hot when subjected to an electrical current; a product storage chamber for storing vaccines or other products having low temperature storage requirements; an axial airflow induction fan; a temperature variance moderation chamber (hereinafter TVMC); a plurality of thermal reservoirs arranged and disposed in the TVMC; a dividing plenum wall dividing said TVMC from said product storage chamber, wherein the evaporator chamber is separated from the product storage chamber by the TVMC, the plurality of thermal reservoirs of the TVMC and the dividing plenum wall acting as a thermal barrier between the evaporator chamber and the product storage chamber; and wherein the volume of said product storage chamber to the volume of said TVMC has a range from 3 to 5.5; and wherein the volume of the product storage chamber relative to said thermal reservoirs total latent heat ratio has a tolerance zone of 0.1 to 1.5 (in3/J/g)); and wherein the temperature of said product storage chamber maintains a temperature of −58 degrees Centigrade and −15 degrees Centigrade during the defrost cycle of the refrigerator.
2. The refrigeration defrost system of claim 1 wherein said TVMC further comprises a dividing plenum wall; a plurality of integrated clips and a plurality of vents positioned to induce convection and sized to optimize thermal transfer to said plurality of said thermal reservoirs.
3. The refrigeration defrost system of claim 2 wherein said TVMC is adjacent to said product storage chamber.
4. The refrigeration defrost system of claim 3 wherein said axial induction fan is approximately 3.5 inches in diameter.
5. The refrigeration defrost system of claim 4 wherein the plurality of thermal reservoirs is four.
6. The refrigeration defrost system of claim 5 wherein the freezing point temperature in said plurality of thermal reservoirs has a minimum delta of zero degrees Centigrade to a maximum delta of −20 degrees Centigrade of the stored product when the stored product is a vaccine.
7. The refrigeration defrost system of claim 6 such that when the temperature of said TVMC and the temperature of said product storage chamber is reduced to the operating range, said plurality of thermal reservoirs loose heat through the process and freeze.
8. The refrigeration defrost system of claim 7 when said digital controller initiates said refrigeration defrost cycle, said plurality of thermal reservoirs absorb heat via free convection in said product storage chamber and maintain the temperature of said product storage chamber below the specified maximum allowed vaccine storage temperature throughout said refrigeration defrost cycle.
9. The refrigeration defrost system of claim 8 wherein said axial induction fan will not be engaged by said digital controller until the air temperature around said evaporator and said evaporator chamber has dropped in temperature ranging from 5 degrees to 20 degrees Fahrenheit after the refrigeration defrost system has undergone said refrigeration defrost cycle defrost cycle.
10. The refrigeration defrost system of claim 9 wherein said plurality of thermal reservoirs and said plenum dividing wall create a barrier between a thermal barrier between said evaporator and said product storage chamber such that the temperature increase induced by said integrated heating element during said refrigeration defrost cycle does not adversely affect the stored product.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
DETAILED DESCRIPTION OF THE INVENTION
(10) The invention generally relates to the field of hybrid refrigeration and the ability to precisely control the temperature, moderate temperature due to heating processes, extend passive temperature control timeframes, better assure product quality and reduce manual maintenance requirements. Refrigeration systems typically rely on intermittent heating cycles to eliminate the accumulation of frost. Typical defrosting technologies raise the temperature of the air within the freezer to levels unacceptable for certain applications due to this heating cycle.
(11) Referring now to
(12) Evaporator 6 is approximately 80 to 160 linear inches of metal tubing approximately 0.25 inches in diameter with fins for heat transfer and integrated evaporator heating element 19 and expansion device 5 such as an orifice or small diameter tube residing within the evaporator chamber 20. Also included in the system is an axial airflow induction fan 7 approximately 3.50 inches in diameter, mounted on the chamber dividing wall 18 and digital controller 9 as manufactured by Dixell (part number XR70 or XR75) that measures chamber temperature and regulates refrigeration system operation. The evaporator heating element 19 is an electrically resistive component that becomes hot when subject to an electric current. The insulated freezer housing 1 is constructed of an inner and outer shell containing an insulating material 2. Access to the interior of the system is provided by a similarly insulated door 3.
(13) Evaporator 6 is separated from the product storage chamber 14 by the temperature variance moderation chamber 12. Chilled air is circulated by the axial airflow induction fan 7.
(14) Temperature variance moderation chamber 12 (the newly defined volume) can be constructed from plastic or metal.
(15) Temperature variance moderation chamber (herein after “
(16)
(17) Product 15 is contained in product storage chamber 14. The product 15 can be stored loose or contained in trays or baskets 16.
(18) Proportionalities and relationships between the various elements in this embodiment are critical to successful operation and are identified as follows:
(19) Product storage chamber 14 volume relative to the temperature variance moderation chamber 12 volume ratio is nominally 4.6 having a tolerance zone of 3 to 5.5.
(20) Product storage chamber 14 volume relative to the thermal reservoirs 10 total latent heat ratio is nominally 0.8 (in.sup.3/(J/g)) having a tolerance zone of 0.1 to 1.5 (in.sup.3/(J/g)).
(21) Product storage chamber 14 area relative to dividing plenum wall 11 inward surface area ratio is nominally 3.1 having a tolerance zone of 1 to 10.
(22) Dividing plenum wall 11 inward surface relative to the total thermal reservoir 10 surface area ratio is nominally 1.8 having a tolerance zone of 0.5 to 4.0.
(23) Product storage chamber 14 is maintained at a minimum delta of 0° C. lower temperature to a maximum delta of −8° C. lower temperature than the freezing point of thermal reservoir 10.
(24) Product storage chamber 14 is maintained at a minimum delta of 0° C. lower temperature to a maximum delta of −20° C. lower temperature than the recommended storage temperature when the stored product is frozen vaccine.
(25) Thermal reservoirs 10 freezing point temperature is a minimum delta of 0° C. lower temperature to a maximum delta of −20° C. lower temperature than the recommended storage temperature of the stored product 15 when the stored product is vaccine.
(26) At storage, the refrigeration systems draws down the temperature of the product storage chamber 14 using a typical vapor compression cycle utilizing R600, R290 or a mixture of the two as a refrigerant.
(27) As temperature variance moderation chamber 12 and product storage chamber 14 temperature is reduced to the minimum operating range (typically −30° C.); thermal reservoirs 10 loose heat through the process and freeze.
(28) When digital controller 9 initiates an automatic defrost cycle and the refrigeration system is inactive, thermal reservoirs 10 absorb heat via free convection in product storage chamber 14 and maintain the temperature of product storage chamber 14 below the critical vaccine storage temperature throughout the defrost cycle.
(29) Critically, as a process parameter, axial airflow induction fan 7 will not engage until the air temperature around evaporator 6 and in the evaporator chamber 20 has dropped to between −5° C. and −20° C. after a defrost cycle.
(30) Critically, thermal reservoirs 10 and plenum dividing wall 11 create a thermal barrier between evaporator 20 and product storage chamber 14 so the temperature increase induced by evaporator heating element 19 during a defrost cycle does not adversely affect the stored frozen vaccine 15.
(31) The following definitions are used for the following description of the invention as shown in
(32) T
(33) T
(34) T
(35) T
(36) Operational Cycle and Thermo-Physical Properties
(37) Now referring to
(38) Process and Thermo-Physical Effects of State i
(39) Frost builds up during normal operation within the product chamber 1,
(40) Defrost Cycle
(41) Referring now to
(42) Process and Thermo-Physical Effects in the Defrost Mode
(43) Fan 7 operation is halted. This prevents convection and greatly reduces air transport between the three chambers; that is, evaporator chamber 20,
(44) Phase iii—Drip Delay and Evaporator Cool-Down Mode
(45) Referring now to
(46) Process and Thermo-Physical Effects of this Mode
(47) The active heated defrost cycle ends. Water continues to drip, drain or evaporate. Evaporator chamber 20 cools down due to the cooler temperatures of the surrounding components (driven by heat absorption to the surrounding components thermal capacities) and thermal reservoirs 10 which continues to absorb heat via phase transition. The air in evaporator chamber 20 achieves a temperature below the freezing point of water before fan 7 engages for the next phase (refrigeration restart). Then, the drip cycle ends. Most of the water vapor in evaporator chamber 20 condenses during this phase as frost on evaporator 20, and walls and cooled evaporator surfaces prior to induced air circulation into
(48) Phase iii—Refrigeration Restart
(49) Now referring to
(50) Process and Thermo-Physical Effects of this Phase
(51) Compressor 4 then restarts thus inducing active refrigeration. Evaporator 6 temperature pulls down to normal operating steady-state temperature. After a timed-delay, fan 7 restarts and induces airflow within all chambers. The temperature in product chamber 14 pulls down to normal steady-state operating temperature. The temperature in thermal reservoirs 10 pulls down to normal operating steady-state temperature. Reservoirs 10 absorb latent heat required for the solidification phase transition and continues to drop in temperature to a frozen solid. The bulk of the vapor in the system (evaporator chamber 20,
(52) It is at this stage that a great differential in vapor partial pressure driven sublimation begins to accelerate. Since thermal reservoir 10 requires a significant tonnage of refrigeration after the defrost cycle to pull down to phase transition temperature and then to supply the latent heat of phase transition, product chamber 14 stays at a higher temperature relative to evaporator chamber 20. Evaporator 6 has a longer timeframe than would be experienced with a standard freezer with an auto-defrost capability.
(53) The effect of this longer timeframe with a greater average temperature differential is to drive accelerated sublimation in product chamber 14. This is due to the greatly reduced vapor partial pressure thus setting up a high driving potential. The effect of the overall process cycle (all States included) is to continually reduce the total ice and vapor content within the three chambers (evaporator chamber 20,
(54) Although the present invention has been described with reference to certain preferred embodiments thereof, other versions are readily apparent to those of ordinary skill in the preferred embodiments contained herein.